Robert Bowser

Company: Barrow Neurological Institute

Job title: Chief Scientific Officer

Seminars:

Exploring a New Window of Opportunity: TDP-43-Related Biomarkers & Their Development into Clinical Use 8:35 am

With a pressing need for more disease-specific markers of ALS pathology, a promising avenue has emerged to explore the downstream effects of cryptic exon inclusion due to TDP-43 loss of function. For example, the generation of a novel peptide, leading to the development of methods to specifically detect it in individuals with ALS. Join this…Read more

day: Pre-Conference Day